This study describes group A rotavirus (RVA) genotype prevalence in Belarus from 
Introduction
Group A rotavirus (RVA) is a well-known etiological agent of acute gastroenteritis that mostly affects small children. The virus is widespread and plays a dominant role among causative agents of acute gastroenteritis both in developed and developing countries. It is believed that every child has an RVA infection at least once before 5 years of age. Moreover, RVA often causes a severe form of gastroenteritis (RVGE) with severe dehydration that often requires oral or intravenous rehydration (Sack et al., 1978) . Inadequate therapy can lead to a lethal outcome which is a serious problem for developing countries and is estimated to result in 453,000 deaths annually prior to the introduction of vaccination (Tate et al., 2012) .
RVA is a nonenveloped virus that belongs to the Reoviridae family. The virus genome contains 11 segments of double-stranded RNA that code 6 structural and 6 nonstructural proteins (Estes and Kapikian, 2007) . RVA have two independently segregating serotype antigens, outer capsid proteins VP4 (P type) and VP7 (G type) coded by segments 4 and 9, respectively (Estes and Kapikian, 2007) . There are at least 27 different G genotypes and 35 P genotypes known today . Among at least 12 G types and 15 P types identified in humans, more than 70 G-P antigen combinations have been detected Usonis et al., 2012) . In the last 2 decades genotype G1P [8] has been predominant, being responsible for about 70% of RVA gastroenteritis in Europe (Santos and Hoshino, 2005) . Recently, G9P[8] emerged in different parts of the world and now represents a globally common strain that is apparently becoming more widespread over time and it has been suggested that genotype G12 is also emerging to potentially become another globally important strain Matthijnssens et al., 2010) .
Development of new RVA vaccines and their recent licensing in many countries has resulted in the inclusion of RVGE as another vaccine preventable disease. Consequently, surveillance studies are needed in countries considering the use of RVA vaccines to monitor strain prevalence. In the Belarus laboratory, diagnosis of RVA infection by using enzyme immunoassays (commercial kits as well those produced in the Republican Research and Practical Center for Epidemiology and Microbiology) has been conducted for about 15 years but information concerning genotypic diversity of circulating viruses in Belarus is still very limited with only 4 reports published in Russian (Gudkov et al., 2011; Gudkov et al., 2008; Gudkov et al., 2010; Samoilovich et al., 2013) . The purpose of this study was to determine circulating RVA genotypes in Belarus during 2008-12. This information will help establish the impact of future RVA vaccination programs in the country.
Materials and methods
All specimens were convenience samples from children admitted to infectious disease hospitals with a diagnosis of acute RVGE. The stool samples were tested first using a solid phase enzyme immunoassay (EIA for rotavirus antigen revealing, Republican Research and Practical Center for Epidemiology and Microbiology, Belarus). Specimens for genotyping were selected randomly from EIA-positive samples and total of 633 stool specimens were characterized. In 2008, specimens were collected in three regions of Belarus: 115 specimens from the capital Minsk-City (central part of the country), 16 specimens from Brest region (western part of the country), and 13 specimens from the Mogilev region (eastern part of the country). Viral RNA was extracted from 10% stool suspensions prepared in PBS using a KingFisher Extraction system (Thermo Electron Corp, Finland). G (VP7) and P (VP4) typing were carried out by reverse transcription-polymerase chain reaction (RT-PCR) genotyping as described previously (Hull et al., 2011) . Genotype determination of non-typeable samples was performed by nucleotide sequencing as described previously (Hull et al., 2011) .
Results
Of the 633 specimens, G types could be assigned to 628 samples and 5 were G non-typeable (NT). P types were determined for 629 specimens. The predominant G types detected were G1, G2, G3, and G4. Among them G4 type was predominant (336 strains, 53.5%) followed by G2 (105 strains, 16.7%), G3 (101 strains, 16.1%) and G1 (72 strains, 11.5%). Genotypes G9 (5 strains, 0.8%), and G8 (2 strains, 0.3%) were less frequently detected. Among the VP4 specificities, genotype P[8] was most frequent and represented by 80.9% (509 strains) and P[4] was detected in 106 samples (16.9%). Genotypes P[6] and P [9] were present at rates of 1.3 and 0.8%, respectively. The most common G-P combination among the 624 G and P-typed samples was G4P Figure 1 ). Genotype G4P [8] was predominant in each of three locations studied: Brest region -81.3% (13 cases), Mogilev region -53.8% (7 cases), Minsk -58.3% 9 (67 cases). In the Brest region, the other genotype detected was G1P and G9P[8] were also detected at low levels along with some G or P non-typeable strains (Figure 1 ). Although the data obtained demonstrate some differences in genotype distribution in 3 regions, the small number of samples tested makes it difficult to ascribe significance to the noted variation in genotypes.
Temporal variation in RVA genotype distribution-Minsk
The 2008 
Discussion
Worldwide RVA surveillance has permitted establishment of the most common genotypes for different geographic areas . At the same time, current studies that are being carried out in many countries that have not previously been surveyed, provide new data and constantly update our knowledge of the prevalence and epidemiological significance of individual RVA genotypes. (Gudkov et al., 2011; Gudkov et al., 2008; Gudkov et al., 2010; Samoilovich et al., 2013) . This is in contrast to results of contemporary studies conducted in other European countries which demonstrated that genotype G1P [8] was the predominant strain in the region in most years Ruggeri et al., 2011; Vesikari et al., 2013) . However, molecular epidemiological data indicate that in the last three decades genotype G4P [8] played an important role in the European region and other parts of the world as a causative agent of RVGE, being responsible for up to 60% of annual cases in various countries (Arista et al., 1997; Bon et al., 2000; Buesa et al., 2000; Iturriza-Gomara et al., 2011; Koopmans and Brown, 1999; Mirzayeva et al., 2009; Ogilvie et al., 2011; Usonis et al., 2012) . In certain periods, G4P[8] strains were identified as the most prevalent genotype in Spain in 1996 (Buesa et al., 2000) , in Italy at the beginning of 1990s (Arista et al., 1997 ), in Albania, Bulgaria, and Russia in 2005 -06 and Hungary in 2007 -11 (Laszlo et al., 2012 Ogilvie et al., 2011) . In this study, G4P[8] was identified as a predominant genotype in all years except 2011 and in all 3 regions investigated in 2008, thus confirming the high epidemiological significance of this genotype for Belarus.
Genotype G2P[4] was the second most frequently identified genotype in Belarus; it was detected in 16.5% of specimens in the study and comprised 30% of genotyped samples in 2009. It is interesting to note that the peak prevalence of this genotype in 2009 was preceded by very low level activity in 2008 (2.0% prevalence, with all cases from Minsk) and followed by a decrease in prevalence to 10.2% in 2010. Large annual fluctuations in G2P [4] prevalence have been noted in other countries (Dulgheroff et al., 2012; Esteban et al., 2010; Giammanco et al., 2014; Mladenova et al., 2010) . A similar trend albeit with a broader temporal peak was observed for the 3 rd most frequently identified genotype, G3P[8], which exhibited a peak level of detection in 2011 (65% prevalence) and detection frequencies of ) was found rarely with only 5 detections in Belarus during the 5-year course of this study.
There were two uncommon genotypes in Belarus and both of them were characterized by presence of P[6] type VP4 protein in combination with G4 and G2 types. In general, P[6] type is not frequently detected in Europe Papp et al., 2013; Usonis et al., 2012) . The P[6] genotype, paired with a variety of G types (G1, G2, G4, G8, G9), has been detected in RVGE specimens primarily from Africa and India (Gentsch et al., 2005; Santos and Hoshino, 2005) . The very low level frequency of detection of G2/4P[6] strains in this study is consistent with other RVA prevalence reports from Europe.
A limitation of the study was that the samples were collected and tested during all the years of the study for only one site (Minsk City) and that data for multiple regions were available for 2008 only. This is due to fact that the stool samples collected were convenience samples collected through passive surveillance. Thus we could not collect equivalent numbers of samples from all regions of Belarus to better define the predominant RVA each year. If future funding permits, we would perform active RVA surveillance with recruitment of cases, paid staff for sample collection and shipment to increase the number of samples and annual study sites. Ideally this type of surveillance can be introduced before RVA vaccine introduction and maintained during the vaccine use era.
Conclusion
This study represents the first detailed multi-year report of RVA genotype prevalence in Belarus. The results of this study will help assess future vaccine effectiveness studies in Belarus by potentially identifying changes in genotype distribution post-vaccine introduction and the emergence of strains that have escaped immunity elicited by RVA vaccines. Infect Genet Evol. Author manuscript; available in PMC 2015 October 24.
